Jin-Ping Lai

1.1k total citations
17 papers, 899 citations indexed

About

Jin-Ping Lai is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jin-Ping Lai has authored 17 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jin-Ping Lai's work include Fibroblast Growth Factor Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jin-Ping Lai is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jin-Ping Lai collaborates with scholars based in United States, Switzerland and Germany. Jin-Ping Lai's co-authors include Lewis R. Roberts, Dalbir S. Sandhu, Markku Miettinen, Chyi‐Chia Richard Lee, Abdirashid M. Shire, Viji Shridhar, Jeremy C. Smith, Julie Staub, Jeremy Chien and Eddie L. Greene and has published in prestigious journals such as Gastroenterology, Oncogene and Clinical Cancer Research.

In The Last Decade

Jin-Ping Lai

17 papers receiving 882 citations

Peers

Countries citing papers authored by Jin-Ping Lai

Since Specialization

Citations

This map shows the geographic impact of Jin-Ping Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-Ping Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-Ping Lai more than expected).

Fields of papers citing papers by Jin-Ping Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-Ping Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-Ping Lai. The network helps show where Jin-Ping Lai may publish in the future.

Co-authorship network of co-authors of Jin-Ping Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-Ping Lai. A scholar is included among the top collaborators of Jin-Ping Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-Ping Lai. Jin-Ping Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Primary Angiosarcoma of the Pancreas 2016 ·Journal of Gastrointestinal Cancer ·(unknown), (unknown), Jula Veerapong, Yongxin Chen, Dengfeng Cao, (unknown), Jin-Ping Lai	9
2	Synchronous Ileal Neuroendocrine Tumor and Ovarian Steroid Cell Tumor Present in a Female With Hyperandrogenism 2016 ·International Journal of Gynecological Pathology ·Stuart R. Gray, Yongxin Chen, (unknown), Bassel Jallad, (unknown), John Hoff, (unknown), Jason Taylor, Jula Veerapong, Jin-Ping Lai	2
3	The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D) 2013 ·Acta Neuropathologica Communications ·Jin-Ping Lai, (unknown), Meghna Alimchandani, Qingyan Liu, Phyu P. Aung, Kant Matsuda, Chyi‐Chia Richard Lee, Maria Tsokos, Stephen M. Hewitt, Elisabeth J. Rushing, Deborah Tamura, David Levens, John J. DiGiovanna, Howard A. Fine, Nicholas J. Patronas, Sikandar G. Khan, David E. Kleiner, J. Carl Oberholtzer, Martha Quezado, Kenneth H. Kraemer	37
4	Gastrointestinal Histopathology in Chronic Granulomatous Disease 2013 ·The American Journal of Surgical Pathology ·Meghna Alimchandani, Jin-Ping Lai, Phyu P. Aung, (unknown), Natasha Kamal, John I. Gallin, Steven M. Holland, Harry L. Malech, Theo Heller, Markku Miettinen, Martha Quezado	66
5	NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis 2012 ·Modern Pathology ·Jin-Ping Lai, Paul F. Robbins, Mark Raffeld, Phyu P. Aung, Maria Tsokos, Steven A. Rosenberg, Markku Miettinen, Chyi‐Chia Richard Lee	90
6	NY-ESO-1 expression in sarcomas 2012 ·OncoImmunology ·Jin-Ping Lai, Avi Z. Rosenberg, Markku Miettinen, Chyi‐Chia Richard Lee	44
7	KBA62 and PNL2 2011 ·The American Journal of Surgical Pathology ·Phyu P. Aung, Maarit Sarlomo‐Rikala, Jerzy Lasota, Jin-Ping Lai, Zeng-Feng Wang, Markku Miettinen	22
8	A facile and general approach for the synthesis of fluorescent silica nanoparticles doped with inert dyes 2011 ·Chinese Science Bulletin ·Xue Mu, (unknown), Jin-Ping Lai, (unknown), (unknown), Chong Li, (unknown)	14
9	Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors 2010 ·Liver International ·Jin-Ping Lai, Dalbir S. Sandhu, Chunrong Yu, Catherine D. Moser, Chunling Hu, Abdirashid M. Shire, Ileana Aderca, Linda M. Murphy, Alex A. Adjei, Schuyler O. Sanderson, Lewis R. Roberts	26
10	The Tumor Suppressor Function of Human Sulfatase 1 (SULF1) in Carcinogenesis 2008 ·Journal of Gastrointestinal Cancer ·Jin-Ping Lai, Dalbir S. Sandhu, Abdirashid M. Shire, Lewis R. Roberts	77
11	The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX 2008 ·Journal of Hepatology ·Ileana Aderca, Catherine D. Moser, (unknown), Ahmad BaniHani, (unknown), (unknown), Abdirashid M. Shire, Sophie C. Cazanave, (unknown), Teresa A. Mettler, Lawrence J. Burgart, David M. Nagorney, Stephen N. Thibodeau, Julie M. Cunningham, Jin-Ping Lai, Lewis R. Roberts	43
12	Treatment options for hepatocellular carcinoma 2008 ·Expert Review of Gastroenterology & Hepatology ·Dalbir S. Sandhu, (unknown), Jin-Ping Lai, Lewis R. Roberts	27
13	Heparin-Degrading Sulfatases in Hepatocellular Carcinoma: Roles in Pathogenesis and Therapy Targets 2008 ·Future Oncology ·Jin-Ping Lai, James Thompson, Dalbir S. Sandhu, Lewis R. Roberts	42
14	Abrogation of MAPK and Akt Signaling by AEE788 Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis through Reactive Oxygen Species Generation 2007 ·Clinical Cancer Research ·Chunrong Yu, Bret B. Friday, Jin-Ping Lai, Andrea K. McCollum, Peter Atadja, Lewis R. Roberts, Alex A. Adjei	70
15	Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways 2006 ·Molecular Cancer Therapeutics ·Chunrong Yu, Bret B. Friday, Jin-Ping Lai, Lin Yang, Jann N. Sarkaria, Neil E. Kay, Christopher A. Carter, Lewis R. Roberts, Scott H. Kaufmann, Alex A. Adjei	85
16	HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma 2004 ·Oncogene ·Jin-Ping Lai, Jeremy Chien, Scott E. Strome, Julie Staub, (unknown), Eddie L. Greene, Jeremy C. Smith, Lewis R. Roberts, Viji Shridhar	117
17	hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling 2003 ·Gastroenterology ·Jin-Ping Lai, Jeremy Chien, David J. Moser, Julie Staub, Ileana Aderca, (unknown), Tori A. Matthews, David M. Nagorney, Julie M. Cunningham, Jeremy C. Smith, Eddie L. Greene, Viji Shridhar, Lewis R. Roberts	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact